Lung Cancer Risk Tied to Common Blood Pressure Drugs ACE Inhbitors

Lung Cancer Risk Tied to Common Blood Pressure Drugs, ACE Inhbitors

15:10 EDT 24 Oct 2018 | Drugs.com

WEDNESDAY, Oct. 24, 2018 -- Millions of Americans take angiotensin-converting enzyme (ACE) inhibitors to lower their blood pressure, but a new study suggests they might also increase their odds of developing lung cancer. Among people taking these...

Original Article: Lung Cancer Risk Tied to Common Blood Pressure Drugs, ACE Inhbitors

More From BioPortfolio on "Lung Cancer Risk Tied to Common Blood Pressure Drugs, ACE Inhbitors"